Literature DB >> 16357015

Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.

Vladimir A Snetkov1, Gregory A Knock, Lynne Baxter, Gavin D Thomas, Jeremy P T Ward, Philip I Aaronson.   

Abstract

The mechanisms by which prostaglandin F(2alpha) (PGF(2alpha)) increases intracellular Ca2+ concentration [Ca2+]i in vascular smooth muscle remain unclear. We examined the role of store-, receptor- and voltage-operated Ca2+ influx pathways in rat intrapulmonary arteries (IPA) loaded with Fura PE-3. Low concentrations (0.01-1 microM) of PGF(2alpha) caused a transient followed by a plateau rise in [Ca2+]i. Both responses became maximal at 0.1 microM PGF(2alpha). At higher concentrations of PGF(2alpha), a further slower rise in [Ca2+]i was superimposed on the plateau. The [Ca2+]i response to 0.1 microM PGF(2alpha) was mimicked by the FP receptor agonist fluprostenol, whilst the effect of 10 microM PGF(2alpha) was mimicked by the TP receptor agonist U-46619. The plateau rise in [Ca2+]i in response to 0.1 microM PGF(2alpha) was insensitive to diltiazem, and was abolished in Ca2+-free physiological salt solution, and by pretreatment with La3+, 2-APB, thapsigargin or U-73122. The rises in [Ca2+]i in response to 10 microM PGF(2alpha) and 0.01 microM U-46619 were partially inhibited by diltiazem. The diltiazem-resistant components of both of these responses were inhibited by 2-APB and La3+ to an extent which was significantly less than that seen for the response to 0.1 microM PGF(2alpha), and were also much less sensitive to U-73122. The U-46619 response was also relatively insensitive to thapsigargin. When Ca2+ was replaced with Sr2+, the sustained increase in the Fura PE-3 signal to 0.1 microM PGF(2alpha) was abolished, whereas 10 microM PGF(2alpha) and 0.05 microM U-46619 still caused substantial increases. These results suggest that low concentrations of PGF(2alpha) act via FP receptors to cause IP3-dependent Ca2+ release and store operated Ca2+ entry (SOCE). U-46619 and 10-100 microM PGF(2alpha) cause a TP receptor-mediated Ca2+ influx involving both L-type Ca2+ channels and a receptor operated pathway, which differs from SOCE in its susceptibility to La3+, 2-APB and thapsigargin, does not require phospholipase C activation, and is Sr2+ permeable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357015      PMCID: PMC1805657          DOI: 10.1113/jphysiol.2005.101394

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.

Authors:  Federico Manuel Daray; Ana Itatí Minvielle; Soledad Puppo; Rodolfo Pedro Rothlin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

2.  Determination of signaling pathways responsible for hypoxic pulmonary vasoconstriction: use of the small vessel myograph.

Authors:  Jeremy P T Ward; Vladimir A Snetkov
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

3.  Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta.

Authors:  Angel Cogolludo; Laura Moreno; Lisardo Bosca; Juan Tamargo; Francisco Perez-Vizcaino
Journal:  Circ Res       Date:  2003-09-11       Impact factor: 17.367

4.  Some properties of the contractile system and sarcoplasmic reticulum of skinned slow fibres from Xenopus muscle.

Authors:  K Horiuti
Journal:  J Physiol       Date:  1986-04       Impact factor: 5.182

5.  Receptor-coupled, permeabilized smooth muscle. Role of the phosphatidylinositol cascade, G-proteins, and modulation of the contractile response to Ca2+.

Authors:  T Kitazawa; S Kobayashi; K Horiuti; A V Somlyo; A P Somlyo
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

6.  Ryanodine reveals multiple contractile and relaxant mechanisms in vascular smooth muscle: simultaneous measurements of mechanical activity and of cytoplasmic free Ca2+ level with fura-2.

Authors:  T Hisayama; I Takayanagi; Y Okamoto
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

7.  Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry.

Authors:  Gavin D Thomas; Vladimir A Snetkov; Rupal Patel; Richard M Leach; Philip I Aaronson; Jeremy P T Ward
Journal:  Cardiovasc Res       Date:  2005-10-01       Impact factor: 10.787

8.  Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin.

Authors:  A B Bradley; K G Morgan
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

9.  Effect of changes in pH on wall tension in isolated rat pulmonary artery: role of the RhoA/Rho-kinase pathway.

Authors:  Jean-Marc Hyvelin; Clare O'Connor; Paul McLoughlin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-06       Impact factor: 5.464

10.  5-HT induces an arachidonic acid-sensitive calcium influx in rat small intrapulmonary artery.

Authors:  Christelle Guibert; Roger Marthan; Jean-Pierre Savineau
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-01-29       Impact factor: 5.464

View more
  14 in total

1.  The small GTPase Rac1 is required for smooth muscle contraction.

Authors:  Awahan Rahman; Benjamin Davis; Cecilia Lövdahl; Veena T Hanumaiah; Robert Feil; Cord Brakebusch; Anders Arner
Journal:  J Physiol       Date:  2013-12-02       Impact factor: 5.182

Review 2.  Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.

Authors:  Demosthenes G Papamatheakis; Madalitso Chundu; Arlin B Blood; Sean M Wilson
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

3.  Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity.

Authors:  Yun Tai Kim; Sang Kwan Moon; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurobiol Dis       Date:  2012-06-16       Impact factor: 5.996

Review 4.  Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels.

Authors:  Florian Veit; Oleg Pak; Ralf P Brandes; Norbert Weissmann
Journal:  Antioxid Redox Signal       Date:  2015-02-20       Impact factor: 8.401

5.  Mechanisms of U46619-induced contraction of rat pulmonary arteries in the presence and absence of the endothelium.

Authors:  C McKenzie; A MacDonald; A M Shaw
Journal:  Br J Pharmacol       Date:  2009-04-22       Impact factor: 8.739

6.  Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release.

Authors:  Michelle J Connolly; Jesus Prieto-Lloret; Silke Becker; Jeremy P T Ward; Philip I Aaronson
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

7.  Mechanisms of U46619- and 5-HT-induced contraction of bovine pulmonary arteries: role of chloride ions.

Authors:  V R Alapati; C McKenzie; A Blair; D Kenny; A MacDonald; A M Shaw
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

8.  Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca(2+) sensitization.

Authors:  Greg A Knock; Vladimir A Snetkov; Yasin Shaifta; Michelle Connolly; Svetlana Drndarski; Anthony Noah; Ghazaleh E Pourmahram; Silke Becker; Philip I Aaronson; Jeremy P T Ward
Journal:  Free Radic Biol Med       Date:  2008-12-06       Impact factor: 7.376

9.  Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry.

Authors:  Vladimir A Snetkov; Gavin D Thomas; Bonnie Teague; Richard M Leach; Yasin Shaifta; Greg A Knock; Philip I Aaronson; Jeremy P T Ward
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

Review 10.  G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential.

Authors:  Zeinab Vahidinia; Mohammad Taghi Joghataei; Cordian Beyer; Mohammad Karimian; Abolfazl Azami Tameh
Journal:  Mol Neurobiol       Date:  2021-06-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.